Closed System Transfer Devices Market Size, Share, Trends, Industry Analysis Report: By Type (Needleless Systems and Membrane-to-Membrane Systems), Component, Technology, Closing Mechanism, End User, Distribution Channels, and Region (North America, Europ

Closed System Transfer Devices Market Size, Share, Trends, Industry Analysis Report: By Type (Needleless Systems and Membrane-to-Membrane Systems), Component, Technology, Closing Mechanism, End User, Distribution Channels, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025-2034

The global closed system transfer devices market size is expected to reach USD 4,753.71 million by 2034, according to a new study by Polaris Market Research. The report “Closed System Transfer Devices Market Size, Share, Trends, Industry Analysis Report, By Type (Needleless Systems and Membrane-to-Membrane Systems), Component, Technology, Closing Mechanism, End User, Distribution Channels, and Region, Market Forecast, 2025-2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

A closed system transfer device (CSTD) is a medical device that effectively blocks the transfer of contaminants within medical systems, preserving the sterility of the fluid pathway. CSTDs regulate the inflow and outflow of both contaminants and drugs, ensuring that the medication infused into a patient remains uncontaminated.

Closed system transfer devices offer a secure method for transferring drugs, significantly reducing the risk of exposure to hazardous substances for both healthcare workers and patients. With healthcare providers and pharmaceutical companies increasingly prioritizing safety in chemotherapy, the demand for CSTDs is anticipated to grow steadily. The global increase in cancer cases is a major factor driving the rising need for these devices.

Acquisition and collaboration with key players to create CSTDs for specific drugs presents significant opportunities for CSTD manufacturers. By tailoring solutions to address the unique needs of different medications, these manufacturers can enhance safety and efficiency in drug transfer. Such acquisition led to the development of innovative CSTDs, contributing to market growth and offering differentiation in a competitive landscape.

For instance, CORMED, a major provider of medical devices, has announced its acquisition of Halo, a Closed System Transfer Device (CSTD) introduced by Corvida Medical, an emerging innovator in the safe handling of unsafe drugs. This acquisition enables CORMED to broaden its product portfolio within the CSTDs market, reinforcing its position as a foremost player in the industry.

Closed System Transfer Devices Market Report Highlights

In 2024, the needleless systems segment held a significant share due to their enhanced safety features, which reduce the risk of needlestick injuries and contamination.

The oncology centers & clinics are expected to witness the highest growth during the forecast period due to the rising incidence of cancer and the increasing demand for chemotherapy and other cancer treatments.

The North American closed system transfer devices market accounted for the largest share in 2024 due to several factors, including stringent regulatory requirements. The region's advanced medical technology landscape and strong focus on safety and compliance further contribute to its leading position in the market.

The closed system transfer devices market in Asia Pacific is expected to grow at the highest CAGR from 2025 to 2034 due to rapid economic development, expanding healthcare infrastructure, and increasing awareness of drug safety. The rising number of cancer cases, coupled with growing investments in healthcare facilities and advancements in medical technology, are fueling demand for CSTDs.

The global key market players include B. Braun Medical Inc.; Baxter; BD; Caragen Ltd.; Cormed; Epic Medical; EQUASHIELD; ICU Medical; JMS North America Corporation; Practivet, Inc.; Simplivia; Terumo Corporation; Vygon; West Pharmaceutical Services, Inc.; YUKON MEDICAL; etc.

Polaris Market Research has segmented the closed system transfer devices market report based on type, component, technology, closing mechanism, end user, distribution channels, and region:

By Type Outlook (Revenue - USD Million, 2020-2034)

Needleless Systems

Membrane-to-Membrane Systems

By Component Outlook (Revenue - USD Million, 2020-2034)

Vial Access Components

Male Luers

Bag Spikes

Female Components

Other Components

By Technology Outlook (Revenue - USD Million, 2020-2034)

Air Cleaning/Filtration Devices

Diaphragm-Based Devices

Compartmentalized Devices

By Closing Mechanism Outlook (Revenue - USD Million, 2020-2034)

Click-to-Lock System

Luer Lock System

Push-to-Turn System

Color-to-Color Alignment System

By End User Outlook (Revenue - USD Million, 2020-2034)

Hospitals

Ambulatory Surgical Centers

Oncology Centers & Clinics

Academic and Research Institutes

Others

By Distribution Channels Outlook (Revenue - USD Million, 2020-2034)

Distributors

Direct Sales

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America

• US
• Canada

Europe

• Germany
• France
• UK
• Italy
• Spain
• Netherlands
• Russia
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Malaysia
• South Korea
• Indonesia
• Australia
• Vietnam
• Rest of Asia Pacific

Middle East & Africa

• Saudi Arabia
• UAE
• Israel
• South Africa
• Rest of Middle East & Africa

Latin America

• Mexico
• Brazil
• Argentina
• Rest of Latin America